A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
Albuterol and Immune Cell Composition
Condition: Immune Cell Composition Intervention: Drug: Administration of albuterol Sponsor: University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials